top of page
All Posts
Compounded Semaglutide & Tirzepatide in 2025: What Patients Should Know
On February 21, 2025 , the FDA announced that the nationwide shortage of semaglutide injections was resolved. In the months following,...
Joshua Silva, MD
4 hours ago4 min read
Hair Loss During Semaglutide (Wegovy®/Ozempic®) or Tirzepatide (Zepbound®/Mounjaro®) Treatment: FAQ
Worried about hair loss while taking Wegovy®, Ozempic® (semaglutide), Zepbound®, or Mounjaro® (tirzepatdie)? Learn why shedding happens during weight loss and how to prevent it.
Joshua Silva, MD
3 days ago4 min read
The FDA Green List and compounded GLP-1 Medications Semaglutide & Tirzepatide
Learn how the FDA Green List impacts compounded semaglutide and tirzepatide. Understand Import Alert 66-80, patient safety, and what it does not mean.
Joshua Silva, MD
7 days ago4 min read
Wegovy (Semaglutide) Cardiovascular Risk Reduction
Wegovy (semaglutide) is FDA-approved to reduce major heart risks in adults with obesity/overweight and cardiovascular disease. Learn what it means and who qualifies.
Joshua Silva, MD
7 days ago3 min read
bottom of page